I’m partnering with a pioneering early-stage biotech developing first-in-class in vivo CAR-T therapies with proprietary IP and a clear path to clinic. This is a unique opportunity to join at a formative stage, where your decisions directly shape the trajectory of a breakthrough therapeutic platform.
Working closely with the CSO and founding team, you will lead cross-functional project management from preclinical development through to key strategic milestones. This is a role for someone who combines deep scientific understanding with operational excellence in cell & gene therapy, ideally CAR-T, gained in a biotech setting.
Key Responsibilities
* Lead and coordinate cross-functional projects from early discovery through preclinical development
* Manage CROs and vendors, ensuring quality, speed, and value in delivery
* Develop and maintain project plans, budgets, and timelines aligned to strategic goals
* Proactively identify risks, troubleshoot challenges, and keep programs on track
* Support strategic initiatives including fundraising preparation and partnering activities
* Drive clear communication across teams, turning complex data into actionable insights for leadership
About You
* Essential: Experience in cell & gene therapy (CAR-T strongly preferred) within a biotech environment is essential. Pure industry or academia is not the right background for this role.
* Strong grounding in oncology or immunology
* Proven success managing complex, multi-stakeholder life science projects from an operational perspective (not just scientific)
* MSc or higher in biochemistry, immunology, virology, or related field
* Confident in budget management, vendor oversight, and project governance
* Clear communicator who can bridge scientific and business priorities in a fast-moving, entrepreneurial setting
Why Join?
* Be part of a scientifically exceptional team with a truly novel therapeutic approach
* Work directly with founders on high-impact programs at the cutting edge of immuno-oncology
* Influence the full path from preclinical strategy to clinical readiness
* Thrive in a collaborative, agile culture where science meets execution